S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

OTCMKTS:TEAR - TearLab Stock Price, Forecast & News

$0.04
+0.00 (+6.25 %)
(As of 02/18/2020 04:00 PM ET)
Today's Range
$0.04
Now: $0.04
$0.05
50-Day Range
$0.04
MA: $0.04
$0.05
52-Week Range
$0.03
Now: $0.04
$0.15
Volume8,500 shs
Average Volume43,614 shs
Market Capitalization$533,842.50
P/E RatioN/A
Dividend YieldN/A
Beta0.69
TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TEAR
Previous SymbolNASDAQ:TEAR
CUSIPN/A
Phone858-455-6006

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25 million
Book Value($1.83) per share

Profitability

Net Income$-2,250,000.00

Miscellaneous

Employees34
Market Cap$533,842.50
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive TEAR News and Ratings via Email

Sign-up to receive the latest news and ratings for TEAR and its competitors with MarketBeat's FREE daily newsletter.


TearLab (OTCMKTS:TEAR) Frequently Asked Questions

What is TearLab's stock symbol?

TearLab trades on the OTCMKTS under the ticker symbol "TEAR."

When did TearLab's stock split? How did TearLab's stock split work?

TearLab's stock reverse split on the morning of Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab stock prior to the reverse split would have 10 shares after the split.

How were TearLab's earnings last quarter?

TearLab Corp (OTCMKTS:TEAR) announced its quarterly earnings results on Thursday, August, 8th. The medical research company reported ($0.10) EPS for the quarter. The medical research company earned $5.85 million during the quarter. View TearLab's Earnings History.

When is TearLab's next earnings date?

TearLab is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for TearLab.

Has TearLab been receiving favorable news coverage?

News stories about TEAR stock have been trending extremely negative this week, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. TearLab earned a coverage optimism score of -4.0 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for TearLab.

Who are some of TearLab's key competitors?

What other stocks do shareholders of TearLab own?

Who are TearLab's key executives?

TearLab's management team includes the folowing people:
  • Mr. Elias Vamvakas, Exec. Chairman & Sec. (Age 60)
  • Mr. Joseph S. Jensen, CEO & Director (Age 47)
  • Mr. Michael Marquez, Chief Financial Officer (Age 37)
  • Dr. Benjamin Sullivan Ph.D., Chief Scientific Officer (Age 43)
  • Mr. Sam Fakhoury, VP of Quality, Compliance & Supply Chain

How do I buy shares of TearLab?

Shares of TEAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is TearLab's stock price today?

One share of TEAR stock can currently be purchased for approximately $0.04.

How big of a company is TearLab?

TearLab has a market capitalization of $533,842.50 and generates $25 million in revenue each year. TearLab employs 34 workers across the globe.View Additional Information About TearLab.

What is TearLab's official website?

The official website for TearLab is http://www.tearlab.com/.

How can I contact TearLab?

TearLab's mailing address is 150 La Terraza Blvd. Suite 101, Escondido CA, 92025. The medical research company can be reached via phone at 858-455-6006 or via email at [email protected]


MarketBeat Community Rating for TearLab (OTCMKTS TEAR)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  364 (Vote Outperform)
Underperform Votes:  234 (Vote Underperform)
Total Votes:  598
MarketBeat's community ratings are surveys of what our community members think about TearLab and other stocks. Vote "Outperform" if you believe TEAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TEAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel